Benjamin L. Maughan

3.3k citations

167 papers · 2.1k indexed · 1 hit paper · h-index 22

Impact in

Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
Pulmonary and Respiratory Medicine top 1%
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment

Papers in

Cancer Research 69
- Cancer Genomics and Diagnostics 31
- Cancer, Lipids, and Metabolism 25
Pulmonary and Respiratory Medicine 130
- Prostate Cancer Treatment and Research 87
- Renal cell carcinoma treatment 37

Co-authors: Emmanuel S. Antonarakis Neeraj Agarwal David Gill Andrew W. Hahn Brandon LuberHao WangUmang Swami Channing J. Paller
Journals: Journal of Clinical Oncology (63 papers)The Oncologist (9 papers)The Prostate (7 papers)Annals of Oncology (7 papers)Clinical Cancer Research (4 papers)
Partner nations: United States France Denmark

In The Last Decade

Benjamin L. Maughan

143 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide 2017 · 340 citations

Peers

Countries citing papers authored by Benjamin L. Maughan

Since Specialization

Citations

This map shows the geographic impact of Benjamin L. Maughan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin L. Maughan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin L. Maughan more than expected).

Fields of papers citing papers by Benjamin L. Maughan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin L. Maughan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin L. Maughan. The network helps show where Benjamin L. Maughan may publish in the future.

Co-authors

The 25 scholars most cited alongside Benjamin L. Maughan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin L. Maughan Line = papers co-authored together Benjamin L. Maughan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Association of Homologous Recombination Repair Alterations with Outcomes in Patients with Metastatic Hormone-Sensitive Prostate Cancer Clinical Cancer Research ·Chadi Hage Chehade, Ryon P. Graf, Zeynep İrem Özay, Georges Gebrael, Nicolas Sayegh, Gerald Li, Benjamin L. Maughan, Emmanuel S. Antonarakis, Rana R. McKay, Neeraj Agarwal, Umang Swami	2025	0
2	Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor Cancer ·Georges Gebrael, Yeonjung Jo, Vinay Mathew Thomas, Haoran Li, Nicolas Sayegh, Nishita Tripathi, Ayana Srivastava, Blake Nordblad, Emre Dal, Arshit Narang, James Brundage, Patrick Campbell, Gliceida Galarza Fortuna, Chadi Hage Chehade, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami	2024	2
3	Cabazitaxel with abiraterone versus abiraterone alone randomized trial for extensive disease following docetaxel: The CHAARTED2 trial of the ECOG-ACRIN Cancer Research Group (EA8153). Journal of Clinical Oncology ·Christos E. Kyriakopoulos, Yu‐Hui Chen, Robert Jeraj, Fenghai Duan, Jun Luo, Emmanuel S. Antonarakis, Abhishek Tripathi, David Kosoff, Rohan Garje, Russell K. Pachynski, Rahul Atul Parikh, Andrea Harzstark, Nabil Adra, Benjamin L. Maughan, Yousef Zakharia, Paul G. Corn, Glenn Liu, Michael A. Carducci	2024	2
4	Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial BMC Cancer ·Adriana M. Coletta, Lea Haverbeck Simon, Kelsey E. Maslana, Sarah Taylor, Kish Larson, Pamela A. Hansen, Vinay Mathew Thomas, Cornelia M. Ulrich, Manish Kohli, Jonathan Chipman, Umang Swami, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal	2024	1
5	Two phase 2A clinical trials to evaluate the safety and efficacy of IMSA101 in combination with radiotherapy and checkpoint inhibitors in oligometastatic and oligoprogressive solid tumor malignancies. Journal of Clinical Oncology ·Percy Lee, Jyoti Malhotra, Jason Salsamendi, Mona Arbab, Tithi Biswas, (unknown), Matthew P. Deek, Edward G. Garmey, Daniel A. Hamstra, Mai Anh Huynh, Aryavarta M. S. Kumar, Devalingam Mahalingam, Benjamin L. Maughan, Teresa Mooneyham, Nitin Ohri, Krishna Reddy, Gregory Vlacich, Patrick Widhelm, Jason Chao Ye, Robert Timmerman	2024	4
6	Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI JCO Precision Oncology ·Vinay Mathew Thomas, Beverly Chigarira, Georges Gebrael, Nicolas Sayegh, Nishita Tripathi, Roberto Nussenzveig, Yeonjung Jo, Emre Dal, Gliceida Galarza Fortuna, Haoran Li, Kamal Kant Sahu, Ayana Srivastava, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami	2024	1
7	Survival outcomes of apalutamide as a starting treatment: impact in real-world patients with metastatic hormone sensitive prostate cancer (OASIS) Prostate Cancer and Prostatic Diseases ·Benjamin L. Maughan, Yanfang Liu, Suneel Mundle, X. Wang, Mehregan Nematian‐Samani, Lawrence I. Karsh	2024	1
8	Belzutifan for von Hippel–Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study Clinical Cancer Research ·Tobias Else, Eric Jonasch, Othon Iliopoulos, Kathryn E. Beckermann, Vivek Narayan, Benjamin L. Maughan, Stéphane Oudard, Jodi K. Maranchie, Ane B. Iversen, Cynthia M. Goldberg, Wei Fu, Rodolfo F. Perini, Yanfang Liu, W. Marston Linehan, Ramaprasad Srinivasan	2024	11
9	Natural course of metastatic castration‐resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone‐sensitive setting The Prostate ·Georges Gebrael, Chadi Hage Chehade, Nicolas Sayegh, Nishita Tripathi, Beverly Chigarira, Divyam Goel, Blake Nordblad, Taylor Ryan McFarland, Arshit Narang, Ayana Srivastava, Clara Tandar, Emre Dal, Yeonjung Jo, Gliceida Galarza Fortuna, Vinay Mathew Thomas, Kamal Kant Sahu, Haoran Li, Benjamin L. Maughan, Umang Swami, Neeraj Agarwal	2024	1
10	Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural Areas Cancers ·Haoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, Nishita Tripathi, Nicolas Sayegh, Blake Nordblad, Beverly Chigarira, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami	2023	1
11	SYST-18 BELZUTIFAN TREATMENT FOR PATIENTS WITH VON HIPPEL-LINDAU DISEASE–ASSOCIATED CENTRAL NERVOUS SYSTEM HEMANGIOBLASTOMAS ENROLLED IN THE PHASE 2 LITESPARK-004 STUDY Neuro-Oncology Advances ·Vivek Narayan, Othon Iliopoulos, Ane B. Iversen, Benjamin L. Maughan, Kathryn E. Beckermann, Stéphane Oudard, Tobias Else, Jodi K. Maranchie, Wei Fu, Rodolfo F. Perini, Yanfang Liu, W. Marston Linehan, Ramaprasad Srinivasan, Eric Jonasch	2023	1
12	Update on combined immunotherapy for the treatment of advanced renal cell carcinoma Human Vaccines & Immunotherapeutics ·Georges Gebrael, Kamal Kant Sahu, Neeraj Agarwal, Benjamin L. Maughan	2023	20
13	A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancers Heliyon ·Haoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, Blake Nordblad, Nicolas Sayegh, Nishita Tripathi, Vinay Mathew Thomas, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami	2022	2
14	External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer Molecular Cancer Therapeutics ·Umang Swami, Nicolas Sayegh, Yeonjung Jo, Benjamin Haaland, Taylor Ryan McFarland, Roberto Nussenzveig, Divyam Goel, Deepika Sirohi, Andrew W. Hahn, Benjamin L. Maughan, Amir Goldkorn, Neeraj Agarwal	2022	5
15	Oral HIF-2α inhibitor belzutifan for ocular von Hippel-Lindau (VHL) disease Investigative Ophthalmology & Visual Science ·Henry E. Wiley, Hanna R. Coleman, Eric Jonasch, Ramaprasad Srinivasan, Frede Donskov, A. Kruse, Jodi K. Maranchie, Jay Chhablani, Tobias Else, Hakan Demirci, Benjamin L. Maughan, M. Elizabeth Hartnett, Rodolfo F. Perini, Eric K. Park, Emily Y. Chew	2021	4
16	Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell Carcinoma Clinical Cancer Research ·Zeynep Büşra Zengin, Caroline Weipert, Nicholas Salgia, Nazlı Dizman, Joann Hsu, Luís Meza, Alex Chehrazi‐Raffle, Ramya Muddasani, Sabrina Salgia, Jasnoor Malhotra, Neal Shiv Chawla, Errol J. Philip, Lesli A. Kiedrowski, Benjamin L. Maughan, Nityam Rathi, Divyam Goel, Toni K. Choueiri, Neeraj Agarwal, Sumanta K. Pal	2021	18
17	Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform The Oncologist ·Edwin Lin, Andrew W. Hahn, Roberto Nussenzveig, Sergiusz Wesołowski, Nicolas Sayegh, Benjamin L. Maughan, Taylor Ryan McFarland, Nityam Rathi, Deepika Sirohi, Guru Sonpavde, Umang Swami, Manish Kohli, Thereasa A. Rich, Oliver Sartor, Mark Yandell, Neeraj Agarwal	2021	11
18	Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma PLoS ONE ·David D. Stenehjem, Andrew W. Hahn, David Gill, Daniel J. Albertson, Banumathy Gowrishankar, Joseph A. Merriman, Archana M. Agarwal, Venkata J. Thodima, Erik Harrington, Trang H. Au, Benjamin L. Maughan, Jane Houldsworth, Sumanta K. Pal, Neeraj Agarwal	2019	11
19	Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New-onset Metastatic Castration-resistant Prostate Cancer (mCRPC) Molecular Cancer Therapeutics ·Andrew W. Hahn, David Gill, Austin Poole, Roberto Nussenzveig, Sara Wilson, James M. Farnham, Robert A. Stephenson, Lisa Cannon‐Albright, Benjamin L. Maughan, Neeraj Agarwal	2018	9
20	Incidence and Characterization of Antiandrogen Withdrawal Syndrome After Discontinuation of Treatment With Enzalutamide in Castration-resistant Prostate Cancer Clinical Genitourinary Cancer ·Austin Poole, David Gill, Andrew W. Hahn, Eric D. Johnson, Emma Carroll, Kenneth M. Boucher, Roberto Nussenzveig, Benjamin L. Maughan, Neeraj Agarwal	2017	7

About Benjamin L. Maughan

Benjamin L. Maughan is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging and Health Informatics, having authored 167 papers that have together received 2.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (87 papers), Radiopharmaceutical Chemistry and Applications (43 papers), Renal cell carcinoma treatment (37 papers), Cancer Immunotherapy and Biomarkers (31 papers), Cancer Genomics and Diagnostics (31 papers), Cancer, Lipids, and Metabolism (25 papers), Bladder and Urothelial Cancer Treatments (25 papers) and Renal and related cancers (18 papers). The work is most often cited by research in Cancer Research (707 citations), Pulmonary and Respiratory Medicine (1.4k citations), Health Informatics (48 citations), Oncology (915 citations) and Radiology, Nuclear Medicine and Imaging (294 citations). Benjamin L. Maughan has collaborated with scholars based in United States, France and Denmark. Frequent co-authors include Emmanuel S. Antonarakis, Neeraj Agarwal, David Gill, Andrew W. Hahn, Brandon Luber, Hao Wang, Umang Swami, Channing J. Paller, Mario A. Eisenberger and Samuel R. Denmeade. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist, The Prostate, Annals of Oncology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact